Diastereoselective synthesis process with 6-bromo-4-(3-chlorophenyl)-2-methoxyquinoline

Details for Australian Patent Application No. 2005238222 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Filliers, Walter Ferdinand Maria; Angibaud, Patrick Rene; Broeckx, Rudy Laurent Maria

Agent Shelston IP

Pub. Number AU-B-2005238222

PCT Pub. Number WO2005/105783

Priority 04076321.1 03.05.04 EP

Filing date 28 April 2005

Wipo publication date 10 November 2005

Acceptance publication date 28 October 2010

International Classifications

C07D 233/54 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

2 November 2006 PCT application entered the National Phase

  PCT publication WO2005/105783 Priority application(s): WO2005/105783

28 October 2010 Application Accepted

  Published as AU-B-2005238222

24 February 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005238223-Diastereoselective synthesis process for the preparation of imidazole compounds

2005238221-Diastereoselective addition of lithiated N-methylimidazole on sulfinimines